KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Other Working Capital Changes (2016 - 2026)

Bristol Myers Squibb has reported Other Working Capital Changes over the past 18 years, most recently at $1.6 billion for Q1 2026.

  • Quarterly Other Working Capital Changes rose 54.49% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $106.0 million through Mar 2026, up 161.27% year-over-year, with the annual reading at -$471.0 million for FY2025, 24.52% up from the prior year.
  • Other Working Capital Changes was $1.6 billion for Q1 2026 at Bristol Myers Squibb, up from -$1.1 billion in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1.6 billion in Q1 2026 and troughed at -$1.1 billion in Q4 2025.
  • The 5-year median for Other Working Capital Changes is -$167.0 million (2024), against an average of $106.9 million.
  • Year-over-year, Other Working Capital Changes skyrocketed 185.27% in 2022 and then plummeted 383.05% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$700.0 million in 2022, then skyrocketed by 59.57% to -$283.0 million in 2023, then crashed by 156.18% to -$725.0 million in 2024, then crashed by 47.31% to -$1.1 billion in 2025, then skyrocketed by 253.18% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Other Working Capital Changes are $1.6 billion (Q1 2026), -$1.1 billion (Q4 2025), and -$240.0 million (Q3 2025).